| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Anacor Pharmaceuticals Inc | 1,067,892 | 125,702,000 | 41.75% | ||
| 2 | INTRALINKS HLDGS INC | 6,290,503 | 52,148,000 | 17.32% | ||
| 3 | CARA THERAPEUTICS INC | 2,668,057 | 38,127,000 | 12.66% | ||
| 4 | EVERYDAY HEALTH INC | 4,107,522 | 37,543,000 | 12.47% | ||
| 5 | INOTEK PHARMACEUTICALS CORP | 2,870,584 | 26,983,000 | 8.96% | ||
| 6 | RUBICON PROJ INC | 798,381 | 11,600,000 | 3.85% | ||
| 7 | REACHLOCAL INC | 2,570,395 | 5,424,000 | 1.80% | ||
| 8 | Nephrogenex Inc | 1,052,966 | 3,559,000 | 1.18% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001420506-15-000551, filed 2015.11.03).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
